ANTX vs SRPT · $32.0M cap vs rev $1.13B
AN2 Therapeutics Inc (ANTX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ANTX currently screens at market cap $32.0M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ANTX and SRPT stock pages for the full models.
Not investment advice.